Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; and vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
IPO Year:
Exchange: NYSE
Website: centene.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/9/2025 | $70.00 | Overweight | Morgan Stanley |
| 6/2/2025 | $65.00 | Overweight → Equal Weight | Barclays |
| 4/8/2025 | $64.00 | Underperform → Hold | Jefferies |
| 2/6/2025 | Buy → Hold | Argus | |
| 12/17/2024 | $80.00 → $75.00 | Overweight | Analyst |
| 12/13/2024 | $79.00 → $80.00 | Neutral → Buy | UBS |
| 12/10/2024 | $68.00 → $52.00 | Hold → Underperform | Jefferies |
| 7/24/2024 | $83.00 → $69.00 | Buy → Hold | Jefferies |
| 5/30/2024 | $83.00 | Neutral | Robert W. Baird |
| 3/21/2024 | $92.00 → $85.00 | Overweight → Equal-Weight | Stephens |
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO
ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g
New leadership role reflects Centene's focus on ICHRA growth ST LOUIS, Jan. 9, 2025 /PRNewswire/ -- Centene Corporation ("Centene") (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, is pleased to announce that Alan Silver has joined the organization as the President of its Ambetter Health Solutions business, which focuses on ICHRA (Individual Coverage Health Reimbursement Arrangements). This newly created role reflects Centene's belief that consumers increasingly will seek health insurance that offers transparency, customization, choice and convenience. ICHRA plans allow employees to shop on the individual Marketplace and choose the insurance plan
PEMBROKE PINES, Fla., Nov. 7, 2024 /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE:CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024. Zein has nearly two decades of experience in the healthcare industry, including various leadership roles of increasing scope and responsibility at Sunshine Health since joining in 2019. She most recently served as Sunshine Health Chief Product President, where she had oversight of all of Sunshine Health's Medi
ST. LOUIS, Aug. 15, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today that it has appointed Thomas R. Greco to the Centene Board of Directors, effective Aug. 9, 2024. Mr. Greco's term will run through the Company's 2025 annual meeting of stockholders. The appointment of Mr. Greco expands Centene's Board of Directors to 11 members. Mr. Greco is a seasoned operator and executive who brings more than four decades of public company leadership and expertise to Centene. Over the course of his career, he has implemented growth strategies and fostered
TAMPA, Fla., July 31, 2024 /PRNewswire/ -- Big Brothers Big Sisters of America (BBBSA), the nation's preeminent one-to-one youth mentoring organization, today announced the election of its newest Board member, Centene Corporation [Centene] (NYSE:CNC) Executive Vice President (EVP) of External Affairs, Jonathan Dinesman. Centene, a leading healthcare enterprise focused on transforming the health of the communities it serves, has been a long-time partner of BBBSA. Dinesman oversees Federal and State Government Relations; Centene's political action committee; Public Policy; Strat
Current Wellcare President & CEO, Richard Fisher, will join the Operations leadership team under Centene Chief Operating Officer Susan Smith, bringing additional Medicare expertise into Centene's core services operations ST. LOUIS, Jan. 22, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced two appointments. Michael A. Carson joins Centene as President and Chief Executive Officer (CEO) of its Medicare business, Wellcare. Mr. Carson will be responsible for Medicare business performance, strategy and growth and will report to Centene President Ken Fasola. Carson succeeds Richard Fisher, who has
PA Health & Wellness Safe & Sound Program to provide assistance with critical home repairs in Greater Harrisburg area HARRISBURG, Pa., Dec. 11, 2023 /PRNewswire/ -- PA Health & Wellness (PHW), a wholly owned subsidiary of Centene Corporation (NYSE:CNC), and Centene Foundation, the philanthropic arm of Centene Corporation, today announced its new partnership with Habitat for Humanity of the Greater Harrisburg Area to provide critical home repairs to area homeowners as part of the organization's Critical Home Repair program. The new program – PHW Safe & Sound – will cover the cost of eligible interior and exterior structural, electrical, plumbing, HVAC and other critical home repairs so that
Proctor brings more than 20 years of healthcare industry experience and proven leadership to Nebraska Total Care OMAHA, Neb., Nov. 16, 2023 /PRNewswire/ -- Nebraska Total Care, a leading provider of government-sponsored healthcare plans in Nebraska and wholly owned subsidiary of Centene Corporation (NYSE:CNC), announced today that Adam Proctor has been appointed as Plan President and Chief Executive Officer, effective November 19, 2023. Proctor replaces Heath Phillips, who was appointed to President and CEO overseeing Centene's Medicaid, Medicare and Marketplace offerings in Tennessee including Rhythm Health, Wellcare of Tennessee and Ambetter of Tennessee.
ST. LOUIS, Nov. 15, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company"), a leading healthcare enterprise committed to helping people live healthier lives, today announced the appointment of Susan Smith as its Chief Operating Officer (COO), effective January 1, 2024. As COO, Ms. Smith will report to Centene President Ken Fasola and will be responsible for core business operations, population health, the enterprise transformation office, provider experience and quality. She has worked at Centene since June 2023. Ms. Smith brings nearly two decades of expertise in
SACRAMENTO, Calif., June 2, 2025 /PRNewswire/ -- Following Gov. Newsom's declaration of a State of Emergency in San Joaquin County, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), is taking immediate action to support those affected by the Victoria Island Incident. The company's priority is ensuring both its members and healthcare providers have the resources they need during this critical time. Member Prescription Information During a declared State of Emergency, impacted members have two optio
Alongside housing, individuals receive primary care, mental health and substance use support, employment guidance and more personal services to help rebuild their lives SACRAMENTO, Calif., June 3, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), awarded a $2.6 million grant to connect individuals exiting the criminal justice system in Sacramento County to services that support a successful reentry into the community. The grant to Hope Cooperative connects individuals to interim housing and housing navigation, mental and behavioral health care, substance use disorder treatment, employment se
Preventative services, social support, health education and more to improve care access, quality and outcomes SACRAMENTO, Calif., May 29, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans, and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), today announced a partnership investment of more than $7.2 million to expand healthcare services to underserved Californians through mobile health clinics. "Mobile clinics become vital lifelines in rural or resource-limited areas, easing transportation c
The funding is made available through an annual program that addresses barriers to healthcare. AUSTIN, Texas, May 29, 2025 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene (NYSE:CNC), has announced the latest recipients of its annual community and provider grant program. The $200,000 in funding is targeted to address the needs of low-income neighborhoods and communities across Texas. "We're excited to announce the grant recipients for this year and are proud to support these community-based organizations a
Initiative to Increase Access to Fresh Produce in Central and Southern Illinois CHICAGO, May 14, 2025 /PRNewswire/ -- Meridian Health Plan of Illinois, Inc. (Meridian), announced today their ongoing health equity efforts to partner with farmers markets in communities with high food insecurity across central and southern Illinois throughout 2025. Meridian is a provider of government-sponsored managed care services to families, children, seniors, and individuals with complex medical needs and a Centene company (NYSE:CNC). Through this initiative, Meridian will help increase acce
Community-based organizations and providers across Delaware can apply for funding now through June 13, 2025 NEWARK, Del., May 12, 2025 /PRNewswire/ -- Delaware First Health ("DFH"), a leading Medicaid managed care organization in Delaware, and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), today announced an open submission period for grants that will be provided to non-profit, community-based organizations and providers that address social drivers of health. By addressing these conditions—such as lack of access to healthy food, housing insecurity and transportation accessibility—these grants will improve the lives and health of Delawareans. "We are please
Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO
ST. LOUIS, May 2, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its subsidiary, Arizona Complete Health, the largest Medicaid health plan in Arizona, has joined the Arizona Health Care Cost Containment System (AHCCCS) – Arizona's single state Medicaid agency – and three other health plans in reaching a settlement agreement to provide managed care for the Arizona Long Term Care System (ALTCS). The ALTCS program supports nearly 26,000 Arizonans who are elderly and/or have a physical disability (EPD) with physical and behavioral healthcare, as well as pharmacy benefits and home- and co
OKLAHOMA CITY, May 1, 2025 /PRNewswire/ -- Oklahoma Complete Health introduces new and upgraded SoonerSelect benefits to support members. Enhancements to the value-added services aim to improve health outcomes and overall well-being of members. "Oklahoma Complete Health is excited to expand the 2025 offerings to serve our members," said Oklahoma Complete Health's President and CEO Clay Franklin. "Our plan continues to prioritize the health and well-being of Oklahomans and find ways to meet their unique needs." New and upgraded benefits include: New: Diaper ClubStarting July 1,
-- Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 -- First quarter 2025 adjusted diluted EPS of $2.90, up 28% from $2.26 in the first quarter of 2024.17% year-over-year premium and service revenue growth.Membership increases of 29% in Marketplace and 22% in Medicare PDP, compared to the first quarter of 2024.Increased 2025 premium and service revenues guidance by $6.0 billion driven by outperformance in Marketplace enrollment and Medicare member retention.ST. LOUIS, April 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the first quarter ended March 31, 2025. In summary, the 2025 first quarter results were as follows: Total
S-8 - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
SCHEDULE 13G - CENTENE CORP (0001071739) (Subject)
8-K - CENTENE CORP (0001071739) (Filer)
10-Q - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
PX14A6G - CENTENE CORP (0001071739) (Subject)
DEFA14A - CENTENE CORP (0001071739) (Filer)
DEF 14A - CENTENE CORP (0001071739) (Filer)
144 - CENTENE CORP (0001071739) (Subject)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
Morgan Stanley resumed coverage of Centene with a rating of Overweight and set a new price target of $70.00
Barclays downgraded Centene from Overweight to Equal Weight and set a new price target of $65.00
Jefferies upgraded Centene from Underperform to Hold and set a new price target of $64.00
Argus downgraded Centene from Buy to Hold
Analyst resumed coverage of Centene with a rating of Overweight and set a new price target of $75.00 from $80.00 previously
UBS upgraded Centene from Neutral to Buy and set a new price target of $80.00 from $79.00 previously
Jefferies downgraded Centene from Hold to Underperform and set a new price target of $52.00 from $68.00 previously
Jefferies downgraded Centene from Buy to Hold and set a new price target of $69.00 from $83.00 previously
Robert W. Baird initiated coverage of Centene with a rating of Neutral and set a new price target of $83.00
Stephens downgraded Centene from Overweight to Equal-Weight and set a new price target of $85.00 from $92.00 previously
-- Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 -- First quarter 2025 adjusted diluted EPS of $2.90, up 28% from $2.26 in the first quarter of 2024.17% year-over-year premium and service revenue growth.Membership increases of 29% in Marketplace and 22% in Medicare PDP, compared to the first quarter of 2024.Increased 2025 premium and service revenues guidance by $6.0 billion driven by outperformance in Marketplace enrollment and Medicare member retention.ST. LOUIS, April 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the first quarter ended March 31, 2025. In summary, the 2025 first quarter results were as follows: Total
ST. LOUIS, March 18, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 first quarter financial results at approximately 6:00 a.m. ET on Friday, April 25, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9776439 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors
-- 2024 Full Year Diluted EPS of $6.31; Adjusted Diluted EPS of $7.17 -- 2024 adjusted diluted EPS of $7.17, up 7% from $6.68 in 2023.Membership increases of 12% in Marketplace and 50% in Medicare PDP, compared to the fourth quarter of 2023.Executed on capital deployment with $3.0 billion of share repurchases in 2024.Increased 2025 premium and service revenues guidance by $4.0 billion driven by Medicaid revenue and better than expected membership performance during the annual enrollment period in Medicare Advantage and PDP.ST. LOUIS, Feb. 4, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the fourth quarter and year ended December
ST. LOUIS, Jan. 15, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Tuesday, February 4, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 1342288 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, unde
-- 2025 adjusted diluted EPS of greater than $7.25 -- -- Reaffirms 2024 adjusted diluted EPS guidance of greater than $6.80 -- ST. LOUIS, Dec. 12, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company"), a leading healthcare enterprise committed to helping people live healthier lives, today will host its investor day to outline its 2025 financial guidance. "Centene is a mission driven organization, dedicated to delivering high quality outcomes for more than 28 million members, many of whom are among the nation's most medically complex and historically underserved populations. Over the last three years we improved our core operations and invested in the experience of our customer
-- Diluted EPS of $1.36; Adjusted Diluted EPS of $1.62 -- -- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $1.62 in the third quarter of 2024.Premium and service revenues of $36.9 billion in the third quarter of 2024.Membership increases of 22% in Marketplace and 49% in Medicare Prescription Drug Plans, compared to the third quarter of 2023.Continued execution on capital deployment with $1.2 billion of share repurchases during the third quarter of 2024 and an additional $380 million in October, bringing full-year repurchases to $2.4 billion through October 2024.ST. LOUIS, Oct. 25, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the
ST. LOUIS, Oct. 8, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 third quarter financial results at approximately 6:00 a.m. ET on Friday, October 25, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 1267976 to expedite
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.42 ---- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $2.42, up 15% from $2.10 in the second quarter of 2023.Premium and service revenues of $36.0 billion in the second quarter of 2024.Membership increase of 34% in Marketplace, compared to the second quarter of 2023.ST. LOUIS, July 26, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the second quarter ended June 30, 2024. In summary, the 2024 second quarter results were as follows: Total revenues (in millions) $ 39,836 Premium and service revenues (in millions) $
ST. LOUIS, July 2, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 second quarter financial results at approximately 6:00 a.m. ET on Friday, July 26, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 4980577 to expedite c
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to greater than $6.80.Premium and service revenues of $36.3 billion in the first quarter of 2024. Increases 2024 full year premium and service revenue guidance by $1.0 billion.Membership increase of 41% in Marketplace, compared to the first quarter of 2023.ST. LOUIS, April 26, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the first quarter ended March 31, 2024. In summary, the 2024 fir
SC 13G - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)